Davies M, Frch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, Rosenstock J, Shimomura I, Viljoen A, Wadden TA, Lingvay I, STEP 2 Study Group (2021) Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
The blockbuster success of Novo Nordisks Ozempic/Wegovy and Lillys Mounjaro/Zepbound, all injectables, have put GLP-1/GIP agonists on the map, but will new oral drugs be a game-changer
Furthermore, two ongoing clinical trials are investigating the effects of ethosuximide on neuropathy (NCT04431778) and visceral pain (NCT02973542)
What should I eat if I have MTHFR C677T
For individuals with conditions that impair nutrient absorption IV therapy provides a highly effective solution to replenish essential vitamins and minerals